Hazard rates for recurrent and secondary cutaneous melanoma: An analysis of 33,384 patients in the German Central Malignant Melanoma Registry Ulrike Leiter, MD, Petra G. Buettner, PhD, Thomas K. Eigentler, MD, Eva B. Bröcker, MD, Christiane Voit, MD, Harald Gollnick, MD, Wolfgang Marsch, MD, Uwe Wollina, MD, Friedegund Meier, MD, Claus Garbe, MD Journal of the American Academy of Dermatology Volume 66, Issue 1, Pages 37-45 (January 2012) DOI: 10.1016/j.jaad.2010.09.772 Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions
Fig 1 A, Probability of recurrence-free survival after primary cutaneous melanoma (CM) diagnosis according to stages. B, Probability of secondary melanoma–free survival after primary CM diagnosis. Journal of the American Academy of Dermatology 2012 66, 37-45DOI: (10.1016/j.jaad.2010.09.772) Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions
Fig 2 Hazard rates (per person-year) for recurrences according to stages (A); for recurrences according to stages IA and IB (B); and for secondary melanoma (C). Journal of the American Academy of Dermatology 2012 66, 37-45DOI: (10.1016/j.jaad.2010.09.772) Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions
Fig 3 Cumulative hazard function (per person-year) for secondary melanoma. Journal of the American Academy of Dermatology 2012 66, 37-45DOI: (10.1016/j.jaad.2010.09.772) Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions